Grace Therapeutics, Inc. Fair Value Adjustment of Warrants
Grace Therapeutics, Inc. (GRCE) reported Fair Value Adjustment of Warrants of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- Grace Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Grace Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $0.00.
- Grace Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $40.00K, a 96.60% decline year-over-year.
- Grace Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$1.43M.
- Grace Therapeutics, Inc. fair value adjustment of warrants for fiscal 2026 was -$900.00K.
- Grace Therapeutics, Inc. fair value adjustment of warrants for fiscal 2025 was -$3.22M, a 217.96% decline from fiscal 2024.
- Grace Therapeutics, Inc. fair value adjustment of warrants for fiscal 2024 was $2.73M.
- Grace Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was -$10.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $40.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.39M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $40.00K derived: sum of 2 quarters · filed 2026-06-18 | -$1.39M derived: sum of 3 quarters · filed 2026-06-18 | -$900.00K 10-K · filed 2026-06-18 |
| 2025-12-31 | $40.00K 10-Q · filed 2026-02-12 | -$1.39M derived: sum of 2 quarters · filed 2026-02-12 | -$900.00K 10-Q · filed 2026-02-12 | -$3.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | -$1.43M 10-Q · filed 2025-11-13 | -$940.00K 10-Q · filed 2025-11-13 | -$3.58M derived: sum of 3 quarters · filed 2026-08-13 | -$2.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $487.00K 10-Q · filed 2026-08-13 | -$2.15M derived: sum of 2 quarters · filed 2026-08-13 | -$975.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.34M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | -$1.46M derived: sum of 2 quarters · filed 2026-06-18 | -$1.82M derived: sum of 3 quarters · filed 2026-06-18 | -$3.22M 10-K · filed 2026-06-18 |
| 2024-12-31 | $1.18M 10-Q · filed 2026-02-12 | $816.00K derived: sum of 2 quarters · filed 2026-02-12 | -$578.00K 10-Q · filed 2026-02-12 | $448.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | -$362.00K 10-Q · filed 2025-11-13 | -$1.76M 10-Q · filed 2025-11-13 | -$730.00K derived: sum of 3 quarters · filed 2025-11-13 | -$855.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$1.40M 10-Q · filed 2025-08-12 | -$368.00K derived: sum of 2 quarters · filed 2025-08-12 | -$493.00K derived: sum of 3 quarters · filed 2025-08-12 | $1.33M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-23 | $902.00K derived: sum of 2 quarters · filed 2025-06-23 | $2.73M derived: sum of 3 quarters · filed 2025-06-23 | $2.73M 10-K · filed 2025-06-23 |
| 2023-12-31 | -$125.00K 10-Q · filed 2025-02-13 | $1.70M derived: sum of 2 quarters · filed 2025-02-13 | $1.70M 10-Q · filed 2025-02-13 | $1.70M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $1.83M 10-Q · filed 2024-11-13 | $1.83M 10-Q · filed 2024-11-13 | $1.83M derived: sum of 3 quarters · filed 2024-11-13 | $1.83M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 derived: sum of 2 quarters · filed 2024-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-08-09 | $0.00 derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $0.00 derived: sum of 2 quarters · filed 2024-06-21 | $0.00 derived: sum of 3 quarters · filed 2024-06-21 | -$10.00K 10-K · filed 2024-06-21 |
| 2022-12-31 | $0.00 10-Q · filed 2024-02-12 | $0.00 derived: sum of 2 quarters · filed 2024-02-12 | -$10.00K 10-Q · filed 2024-02-12 | -$299.00K derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | -$10.00K 10-Q · filed 2023-11-13 | -$299.00K derived: sum of 3 quarters · filed 2023-11-13 | -$1.13M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$10.00K 10-Q · filed 2023-08-11 | -$299.00K derived: sum of 2 quarters · filed 2023-08-11 | -$1.13M derived: sum of 3 quarters · filed 2023-08-11 | -$4.56M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | -$1.12M derived: sum of 2 quarters · filed 2023-06-23 | -$4.55M derived: sum of 3 quarters · filed 2023-06-23 | -$5.20M 10-K · filed 2023-06-23 |
| 2021-12-31 | -$828.00K 10-Q · filed 2023-02-14 | -$4.26M derived: sum of 2 quarters · filed 2023-02-14 | -$4.91M 10-Q · filed 2023-02-14 | -$2.06M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$3.44M 10-Q · filed 2022-11-14 | -$4.08M 10-Q · filed 2022-11-14 | -$1.23M derived: sum of 3 quarters · filed 2022-11-14 | -$134.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$643.00K 10-Q · filed 2022-08-11 | $2.20M derived: sum of 2 quarters · filed 2022-08-11 | $3.30M derived: sum of 3 quarters · filed 2022-08-11 | $1.27M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-21 | $3.94M derived: sum of 2 quarters · filed 2022-06-21 | $1.92M derived: sum of 3 quarters · filed 2022-06-21 | $2.43M 10-K · filed 2022-06-21 |
| 2020-12-31 | $1.10M 10-Q · filed 2022-02-14 | -$929.00K derived: sum of 2 quarters · filed 2022-02-14 | -$420.00K 10-Q · filed 2022-02-14 | $696.00K derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | -$2.03M 10-Q · filed 2021-11-10 | -$1.52M 10-Q · filed 2021-11-10 | -$402.00K derived: sum of 3 quarters · filed 2021-11-10 | $5.48M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $509.00K 10-Q · filed 2021-08-12 | $1.63M derived: sum of 2 quarters · filed 2021-08-12 | $7.51M derived: sum of 3 quarters · filed 2021-08-12 | $22.45M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.12M 10-K · filed 2020-06-29 | $7.00M derived: sum of 2 quarters · filed 2021-02-09 | $21.94M derived: sum of 3 quarters · filed 2021-02-09 | $1.12M 10-K · filed 2021-06-22 |
| 2019-12-31 | $5.88M 10-Q · filed 2021-02-09 | $20.82M derived: sum of 2 quarters · filed 2021-02-09 | $21.76M 10-Q · filed 2021-02-09 | $26.50M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-09-30 | $14.94M 10-Q · filed 2020-11-16 | $15.87M 10-Q · filed 2020-11-16 | $20.62M derived: sum of 3 quarters · filed 2020-11-16 | |
| 2019-06-30 | $932.00K 10-Q · filed 2020-08-13 | $5.68M derived: sum of 2 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $4.75M 10-K · filed 2020-06-29 | $4.75M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |